News Search Results
Apr 24, 2025, 07:00 ET Oncolytics Biotech® to Showcase New Pancreatic Cancer Data at ASCO Highlighting Pelareorep's Tumor-Fighting Mechanism of Action
and has established itself both nationally and internationally. About Oncolytics Biotech Inc. Oncolytics is a clinical-stage biotechnology company developing pelareorep, an intravenously delivered immunotherapeutic agent. Pelareorep has demonstrated promising results in two randomized
More news about: Oncolytics Biotech® Inc.
Apr 24, 2025, 06:00 ET Flagship Pioneering Unveils Etiome to Pioneer Preemptive Healthcare
Sana Biotechnology (NASDAQ: SANA),
More news about: Flagship Pioneering
Apr 24, 2025, 05:45 ET Shareholders that lost money on Sana Biotechnology, Inc.(SANA) should contact The Gross Law Firm about pending Class Action - SANA
April 24, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Sana Biotechnology, Inc. (NASDAQ: SANA).
More news about: The Gross Law Firm
Apr 24, 2025, 02:28 ET Sun Pharma and Moebius Medical Announce Dual Publications on MM-II's Phase 2b Clinical Trial Results and Mechanism of Action in Osteoarthritis and Cartilage
The US alone accounts for approximately 40% of this market. About Moebius Medical Moebius Medical is a clinical stage biotechnology company that is developing novel pain relief treatments for osteoarthritis. The company was founded in 2008 within the RAD Biomed Accelerator to
More news about: Moebius
Apr 23, 2025, 20:00 ET 前Nike副總裁兼總經理Bert Hoyt加入矽響先創dBio，擔任董事會顧問，推動運動與健康科技發展新里程
盧森堡2025年4月24日 /美通社/ -- 矽響先創Decentralized Biotechnology Intelligence Holding Group Inc.（簡稱dBio）身為運動與健康科技領域的領導創新者，致力於提供先進的可穿戴人工智慧物聯網 (AIoT) 解決方案，將運動表現與即時健康數據完美結合。今日榮幸宣布，Hubertus "Bert
More news about: Decentralized Biotechnology Intelligence Holding Group Inc.
Apr 23, 2025, 20:00 ET Former Nike VP & GM Bert Hoyt Joins dBio to Drive Next-Gen Sports & Health Tech as Board Advisor
LUXEMBOURG, April 23, 2025 /PRNewswire/ -- Decentralized Biotechnology Intelligence Holding Group Inc. (dBio), a leading innovator in sports and health tech, delivering advanced wearable AIoT solutions that seamlessly
More news about: Decentralized Biotechnology Intelligence Holding Group Inc.
Apr 23, 2025, 20:00 ET Nike: Ehemaliger Vizepräsident und Geschäftsleiter Bert Hoyt wird Vorstandsberater bei dBio und treibt die Entwicklung der nächsten Generation von Sport- und Gesundheitstechnologien voran
LUXEMBURG, 24. April 2025 /PRNewswire/ -- Die Decentralized Biotechnology Intelligence Holding Group Inc. (dBio), ein führender Innovator im Bereich Sport- und Gesundheitstechnologie, der fortschrittliche tragbare AIoT-Lösungen
More news about: Decentralized Biotechnology Intelligence Holding Group Inc.
Apr 23, 2025, 20:00 ET Former Nike VP & GM Bert Hoyt Joins dBio to Drive Next-Gen Sports & Health Tech as Board Advisor
LUXEMBOURG, April 24, 2025 /PRNewswire/ -- Decentralized Biotechnology Intelligence Holding Group Inc. (dBio), a leading innovator in sports and health tech, delivering advanced wearable AIoT solutions that seamlessly
More news about: Decentralized Biotechnology Intelligence Holding Group Inc.
Apr 23, 2025, 20:00 ET El exvicepresidente y gerente general de Nike, Bert Hoyt, se une a dBio como asesor de la junta directiva
LUXEMBURGO, 24 de abril de 2025 /PRNewswire/ -- Decentralized Biotechnology Intelligence Holding Group Inc. (dBio), un innovador líder en tecnología deportiva y de salud, que ofrece soluciones AIoT portátiles avanzadas que
More news about: Decentralized Biotechnology Intelligence Holding Group Inc.
Apr 23, 2025, 20:00 ET Nike : l'ancien vice-président et directeur général Bert Hoyt rejoint dBio comme conseiller du conseil d'administration pour promouvoir les technologies de pointe en sport et santé
LUXEMBOURG, 24 avril 2025 /PRNewswire/ -- Decentralized Biotechnology Intelligence Holding Group Inc. (dBio), un innovateur de premier plan dans les technologies du sport et de la santé, offrant des solutions AIoT
More news about: Decentralized Biotechnology Intelligence Holding Group Inc.
Apr 23, 2025, 19:00 ET Adcentrx Therapeutics to Present First Clinical Data for ADRX-0706 Nectin-4 ADC at ASCO 2025
Adcentrx Therapeutics ("Adcentrx"), a clinical-stage biotechnology company redefining Antibody-Drug Conjugate (ADC) therapies for cancer treatment and other life-threatening diseases, will present the first clinical
More news about: Adcentrx Therapeutics
Apr 23, 2025, 14:17 ET DeuteRx CEO Honored with Two Industry Awards for Entrepreneurial Success and Innovation in Biopharma R&D
Ganem, Franz and Elisabeth Roessler Professor, Cornell University. "She has led the start-up or turnaround of nine biotechnology companies or business units and managed global R&D organizations with annual budgets of up to $30 million."
More news about: DeuteRx LLC
![Applicant Tracking System [ATS] Market Size to Surpass $ 6.2 Billion, Globally, by 2031 at 10.0% CAGR - Report by The Insight Partners](https://mma.prnewswire.com/media/2520492/The_Insight_Partners_Logo.jpg?w=300){kind=logo}
Apr 23, 2025, 12:03 ET Applicant Tracking System [ATS] Market Size to Surpass $ 6.2 Billion, Globally, by 2031 at 10.0% CAGR - Report by The Insight Partners
consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials. Contact
More news about: The Insight Partners
Apr 23, 2025, 11:47 ET Courier Express and Parcel Market Size to Surpass $ 595.32 Billion, Globally, by 2031 at 8.5% CAGR - Report by The Insight Partners
consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
More news about: The Insight Partners
Apr 23, 2025, 10:50 ET Enterprise IP Management Software Market Size to Surpass USD 41.28 Billion by 2031 | The Insight Partners
consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials. Contact
More news about: The Insight Partners
Apr 23, 2025, 10:30 ET Video Surveillance Market Size Booms with CAGR 11.4% and Projected to Reach $ 122.81 Billion by 2031 | Exclusive Report by The Insight Partners
consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials. Contact
More news about: The Insight Partners
Apr 23, 2025, 10:00 ET Nikon Instruments Announces Opening of Newest Nikon Center of Excellence at the University of Arizona Cancer Center
worldwide. Each facility makes available the latest innovations in imaging technologies to faculty, staff and students from any academic institution, biotechnology organization or other life sciences facility. This facility hosts six advanced imaging systems including those capable of confocal, super
More news about: Nikon Instruments Inc.
Apr 23, 2025, 10:00 ET NORDIC GROUP B.V. THROUGH ITS SUBSIDIARY NORDIC PHARMA, INC. (U.S.), PRESENTING PATIENT DATA AND PATIENT EXPERIENCE STUDY FOR LACRIFILL® CANALICULAR GEL, A NOVEL THERAPY FOR DRY EYE, AT THE AMERICAN SOCIETY OF CATARACT AND REFRACTIVE SURGERY ANNUAL MEETING
Group B.V., is partnered with well-established global biopharmaceutical companies and is uniquely positioned to leverage its expertise in bringing biotechnology derived medicines, sterile manufacturing and other state-of-the-art technologies to the marketplace. Safe Harbor This press
More news about: Nordic Pharma
Apr 23, 2025, 10:00 ET NORDIC GROUP B.V. THROUGH ITS SUBSIDIARY NORDIC PHARMA, INC. (U.S.), PRESENTING PATIENT DATA AND PATIENT EXPERIENCE STUDY FOR LACRIFILL® CANALICULAR GEL, A NOVEL THERAPY FOR DRY EYE, AT THE AMERICAN SOCIETY OF CATARACT AND REFRACTIVE SURGERY ANNUAL MEETING
Group B.V., is partnered with well-established global biopharmaceutical companies and is uniquely positioned to leverage its expertise in bringing biotechnology derived medicines, sterile manufacturing and other state-of-the-art technologies to the marketplace. Safe Harbor This press
More news about: Nordic Pharma
Apr 23, 2025, 09:02 ET Phenomix Sciences and Mayo Clinic to Present Landmark Research at DDW 2025, Advancing Precision Obesity Medicine
Phenomix Sciences (Phenomix), the first commercial precision obesity medicine biotechnology company, today announced the presentation of 17 groundbreaking studies at
More news about: Phenomix Sciences
Apr 23, 2025, 08:31 ET MetaVia Announces Late-Breaking Poster Presentation on DA-1241 at the EASL Congress 2025
April 23, 2025 /PRNewswire/ -- MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced that an abstract highlighting data from its Phase 2a clinical trial of
More news about: MetaVia Inc.
Apr 23, 2025, 08:00 ET commercetools Enables Lallemand to Build Digital Commerce Experiences
commercetools, the most versatile solution for commerce innovation, today announced that Lallemand, a global leader in industrial biotechnology, has chosen commercetools to build its digital commerce platform for its North American Baking business unit.
More news about: commercetools
Apr 23, 2025, 07:00 ET Repertoire® Immune Medicines Enters into Collaboration and License Agreement with Genentech for the Development of T cell-Targeted Therapies for an Autoimmune Disease
Mass., April 23, 2025 /PRNewswire/ -- Repertoire® Immune Medicines, a biotechnology company pioneering the discovery and development of programmable T cell-targeted immune medicines, today announced that it has entered into a collaboration
More news about: Repertoire Immune Medicines
Apr 23, 2025, 07:00 ET Adcendo ApS to Present Data on its Clinical Stage ADCs ADCE-T02 and ADCE-D01 at the 2025 American Association for Cancer Research (AACR) Annual Meeting
allowing sensitive discrimination between healthy and cancer tissues. About Adcendo ApS: Adcendo ApS is a clinical-stage biotechnology company headquartered in Copenhagen, Denmark, with operations in Boston, Massachusetts.
More news about: Adcendo
Apr 23, 2025, 07:00 ET Adcendo ApS to Present Data on its Clinical Stage ADCs ADCE-T02 and ADCE-D01 at the 2025 American Association for Cancer Research (AACR) Annual Meeting
allowing sensitive discrimination between healthy and cancer tissues. About Adcendo ApS: Adcendo ApS is a clinical-stage biotechnology company headquartered in Copenhagen, Denmark, with operations in Boston, Massachusetts.
More news about: Adcendo